Biogen is committed to meeting all global transparency requirements, including the Physician Payments Sunshine Act in the United States and the European Federation of Pharmaceutical Industries and Associations (EFPIA) Disclosure Code in the European Union. As is our obligation, we record all transfers of value to healthcare professionals and organisations and report pursuant to the applicable local codes and laws. We take care to ensure that the data that we submit is as detailed, comprehensive and clear as possible. This information is an important part of our ongoing collaboration with the healthcare community. Ultimately, the data we submit today can benefit patients in the future.

In Australia: As a member of Medicines Australia, Biogen Australia Pty Ltd endorses the Medicines Australia Code of Conduct, and  has undertaken to be open and transparent when we provide a reportable payment or transfer of value to a healthcare professional.

Reportable payments or transfers of value are:

  • Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant.
  • Airfares, accommodation and/or conference registration fees to attend medical education as part of those services.

Biogen Australia has prepared reports for publication in accordance with the Medicines Australia Code of Conduct, Edition 18 and Australia’s Privacy legislation.

For transfers of value made between 1 October 2015 and 30 September 2016, the reports identify healthcare professionals by name where their consent has been provided, and otherwise report the information, in aggregate. All transfers of value made from 1 October 2016 are reported on a mandatory basis and healthcare professionals should reasonably expect that such transfers of value will be disclosed, by name.

The reports below are designed to be read on this website, and are also provided as a downloadable PDF and CSV files. Reports will be available for at least three years from the date of publication.

To comply with our privacy obligations, the reports may be amended from time to time. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988.

For further information about the details in the report, please go to

Biogen Australia Healthcare Professionals Report 1 November 2017 – 30 April 2018

Biogen Australia Healthcare Professionals Report 1 May – 31 October 2017

Biogen Australia Healthcare Professionals Report 1 November 2016 – 30 April 2017

Biogen Australia Healthcare Professionals Report 1 May – 31 October 2016

Biogen Australia Healthcare Professionals Report 1 Oct 2015 – 30 April 2016